Elevated fibroblast growth factor 21(FGF21) was suggested in cross-sectional studies as an indicator of subclinical diabetic nephropathy. We investigated whether serum FGF21 was predictive of the early stage of diabetic nephropathy. The present paper aims mainly to demonstrate the correlation of FGF21 with the degree of proteinuria in type 2 diabetic patients (T2DM). One hundred twenty four participants diagnosed with T2DM were recruited and they were divided into three study groups according to their albumin/creatinine ratio (ACR): (Normo albumin urea group, Micro albumin urea group, and Macro albumin urea group).Samples of blood and urine were collected to measure different glycemic control and kidney function markers. We conclude that significant correlation between FGF21 with Albuminuria (*p = < 0.001), mean FGF21was highest in macro albumin urea followed by micro albumin urea and lastly Normo albumin urea.
Introduction
Diabetes mellitus (DM) is a sequence of metabolic diseases described as high blood sugar due to insulin excretion defects, insulin action or incorporation of both [1] . Type 2 diabetes (T2DM) makes up around 90 percent of the condition of diabetes [2] . Individuals with type two diabetic mellitus are at elevated risk of both micro vascular complications (including retinopathy, nephropathy a nd neuropathy) and macro vascular complications (including cardiovascular co morbidity) due to hyperglycemia and individual insulin resistance (metabolic) syndrome components [3] . Diabetic nephropathy (DN) is the most common end-stage kidney disease cause in the world and is associated with increased morbidity and mortality in patients with type 1 and type 2 diabetes [4] . Damage in glomeruli leads to loss of protein which appears in urine .The estimated glomerular filtration rate (eGFR) may gradually decrease from normal by more than 90 mL / min/1.73 m2 to less than 15 mL at which point the patient is said to have an end-stage kidney disease (ESKD) [5] . Fibroblast growth factor 21 as a novel biomarker of progressive nephropathy, a hepatoadipokine with pleiotropic metabolic regulatory activities and emerges [6] .Fibroblast growth factor 21 (FGF21) is considered as an endocrine FGF family member that acts as a metabolic regulator for both glucose and lipid metabolism and energy balance [7] . They are a group of peptides that control various biological functions including cell differentiation, cell growth, and angiogenesis is identified [8] .Fibroblast growth factor 21 (FGF21), a circulating factor essentially secreted from the liver, has been shown as an emerging metabolic regulator in various clinical conditions [9] .FGF21 is excreted mainly by the kidneys [10] , the relationship between elevated serum FGF21 and impaired renal function remains unclear. Animal studies have demonstrated various beneficial effects on metabolic parameters after the therapeutic administration of recombinant FGF21. Fibroblast growth factors 21 (FGF21) may play an important role in DN development and progression. FGF21 Protects tissue against increased oxidative stress, so that FGF21 is now considered a stress-responsive hormone in humans. The necessary response element in the FGF21 gene acting an activation transcription factor 4 which involved in the regulation of oxidative stress and its correlation to nuclear factor E2-related factor 2 (Nrf2) gene [11] . Nuclear factor 2-related factor 2 (Nrf2) is a basic leucine zipper transcription factor belonging to the family Cap 'n' Collar (CNC). Activated by different stimuli (including oxidative, electrophilic or phototoxic stress as well as exogenous tiny natural molecules), it is one of the primary players in protecting and restoring cellular homeostasis. Reduced oxidative stress clearance or misfolded and aggregated proteins, indicating insufficient Nrf2 activity, is often associated with diabetes etiology and its consequences [12] . Nrf2 is located in the cytoplasm under physiological circumstances and associates with its inhibitor kelch-like ECH-associated protein 1 (KEAP1). KEAP1 could mediate a fast ubiquitination and consequent degradation of Nrf2 by the proteasome [13] . Nrf2 is free of KEAP1 when cells are exposed to oxidative stress or electrophilic compounds and translocates into the nucleus to bind to antioxidant-responsive elements (AREs) in antioxidant enzyme encoding genes such as NADPH quinine oxidoreductase (NQO1), glutathione S-transferase, hemeoxygenase-1 (HO1), and γ-glut amyl cysteine synthesize, increase their expression in detoxification, ant oxidation and anti-inflammation [14] .Recently, several studies have indicated preventive effect of Nrf2 on high glucose-(HG-) induced oxidative damage in the cultured cells and potentially on the diabetic complications in animal models [15] .
Material and methods
The study was approved by the Health and Medical Human Research Ethics Committee at the Faculty of Medicine, University of Kufa, Iraq, and participants were invited from the Center for Diabetes and Endocrinology, at Al-Sader Teaching Hospital, Al-Najaf, Iraq. One hundred twenty four patients, who were clinically diagnosed with T2DM, were included in this study and they were divided into three study groups according to their albumin/creatinine ratio (ACR): Normo albumin urea group (ACR<30 mg/g), micro albumin urea group (ACR = 30-300 mg/g), and macro albumin urea group (ACR >300 mg/g). All participants were provided with participant information sheet and they were given the opportunity to ask questions and discuss their concerns. Written consents were taken from them before allowing them to be involved in the study. Anthropometric data were collected from all the participants. In addition, five milliliters of venous blood samples were collected following an overnight fast, to measure gyrated hemoglobin, HbA1c (using a boron ate affinity assay of glycohaemoglobin in whole blood), fasting plasma glucose (using glucose oxidize method), serum albumin, creatinine, and urea. Urine samples were also collected to measure urinary albumin using a solid phase, sandwich-format, immune metric assay and creatinine using an enzymatic colorimetric methods, as well as serum FGF21 and Nrf2 using Elabscinse kit, enzyme-linked immune sorbent assay.
Statistical Analysis
Data were transformed into computerized data form and analyzed using the statistical package for social sciences (SPSS) version 25, IBM, US. Descriptive statistics expressed as mean, standard deviation, frequency (No.) and percentage (%) according to the variable type. Analysis of variances (ANOVA) test used to assess the significance of differences in mean values of different parameters across the three categories of Albuminuria. Receiver operating characteristics (ROC) curve used for detection of the validity of FGF21, Nrf2, e GFR and ACR in prediction of diabetic nephropathy, area under the curve was calculated which an indicator for the accuracy and ability of a test to predict an outcome, the interpretation of the area under the ROC curve (AUC). By using the ROC curve a cutoff points were generated for each of FGF21, Nrf2 eGFR and ACR. And According to these cutoff points patients were categorized into two subgroups as ≥ cutoff and less than the cutoff point, these subgroups cross-tabulated against diabetic nephropathy either present or not ,then the sensitivity , specificity, accuracy , PPV and NPV. Correlations among different parameters as continuous variables were assessed using Pearson's bivariate analysis. Correlation coefficient (R ) was calculated which is an indicator for the strength and direction of the correlation; statistically the R value ranged between zero (complete no correlation) and one (perfect correlation) and the larger value close to one indicates the stronger correlation, the negative sign (-) of R indicates an inverse correlation while no signed (+) value indicates a direct (positive) correlation. Level of significance (P. value) of 0.05 or less was considered as significant. Finally, results presented in tables and figures using the Microsoft Office for Windows, Word and Excel software, version 2010.
Results
This study showed significant difference in the mean values for,BMI,HbA1c, serum creatinine, serum urea , urine albumin, urine creatinine, and urinary ACR between the patients groups (P < 0.05), also showed no significant difference in the mean values for age, FBS, serum albumin and eGFR between the patients groups (P > 0.05), as shown in Table 1 The mean serum FGF21 was significantly different among all study groups, (*P < 0.05), the mean was highest in macro albumin urea fallowed by micro albumin urea and lastly Normo albumin urea as shown in Table 2 . The mean serum Nrf2 was significantly different among all study groups, (*P < 0.05), the mean was highest in macro albumin urea followed by micro albumin urea and lastly Normo albumin urea, as shown in The person correlation analyses have revealed the relationships between FGF21, NRF2, eGFR and ACR variable studied in the diabetic patient with nephropathy. The result has shown significant positive correlation was seen between Nrf2 with FGF21 (*P=0.001) as shown in Table 5 . 
Discussion
Diabetic nephropathy(DN) is a major micro vascular complication of diabetes mellitus and the most common end-stage kidney disease cause in the world [16] . This study was conducted to evaluate the correlation and to illustrate the diagnostic value of serum FGF21and Nrf2 in T2DM patients with nephropathy with different stages of albuminuria. Results from the current study showed that the DN rate increases with the BMI increase, the mean of BMI highest in macro albumin urea followed by micro albumin urea and lastly Normo albumin urea group, something that has been discussed in previous studies [17] [18] [19] [20] . Age was not a significant between study group.This result was similar to the findings reported by [21] [22] .The present study has showed that age is not important among the patient group due to cross-sectional study and homogeneous population patients. With regard to HbA1c, this present research indicates a mean high level of HbA1c in macro albumin urea followed by micro albumin urea then by Normo albumin urea group (P=0.014) comparable findings are consistent with other research, suggesting that hyperglycemic is the driving force for DN development [23] [24] [25] . In Albuminuria, serum urea levels increase in conjunction with Albuminuria, greater levels were recorded in macro albumin urea followed by micro albumin urea and Normo albumin urea (P=0.003).Similar results have been noted [26] [27] . High blood urea indicates kidney function abnormality. Abnormal urea is a symptom of nephropathy. There is, therefore, a need for early detection of nephropathy [28] . Regarding the level of Albuminuria, there was a significant change in mean serum creatinine among patients group (P=0.035) Macro albumin urea was the greatest mean followed by micro albumin urea and, finally, Normo albumin urea. The study results were similar to those of the studies [29] . Increased creatinine in the blood indicates nephron abnormality. Creatinine is a primarily excretory creatinine metabolite, almost all of which is in the muscle of the skeleton. The liver and kidneys are the main places of creatine synthesis in the human body. In the event of the deranged kidney, high serum creatinine is observed in long-term diabetes [30] . The result of the present study reports the mean FGF21 in Normo albumin urea; micro albumin urea and macro albumin urea were 354.4, 529.4 and 680.4 respectively.
The result of the current study agreed with another study show serum concentration of FGF21 in T2DM with Normo albumin urea, micro albumin urea, and macro albumin urea was 492.30, 595.01 and 665.20 respectively [31] . We found that serum FGF21 level independent associated with albumin creatinine ratio this result agrees with [31] . Also eGFR no significant correlation with FGF21 this result agrees with study [32] . Previous crosssectional studies have shown that circulating FGF21 concentrations in patients with diabetic nephropathy are associated with the renal function [33] . High levels of FGF21 circulating could be a compensatory response to the underlying metabolic disturbances of type 2 DM or FGF21 resistance. Animal studies also showed that a rise in the expression of FGF21 could be a component of a tissue stress-protective reaction. It showed that the expression of pancreatic FGF21 was induced in cerulean-induced acute pancreatitis, which in turn protects the pancreas from further damage. In the diabetic kidney disease, FGF21 expression was considerably up-regulated to 20-fold in the mesangial cells of the renal in db / db mice versus to db / m mice control, although it remains unsure how much of this rise is compensated for by kidney production. In type 2 diabetes, insulin continues an efficient therapy despite the existence of insulin resistance. With respect to FGF21 resistance and early diabetic nephropathy, a comparable situation is probable. On the other side, high serum concentrations of FGF21 could also represent a compensatory reaction to inherent metabolic dysregulation such as insulin resistance, a recognized risk factor for developmental kidney disease. Thus, despite the elevated circulating FGF21 serum concentrations, recombinant FGF21 therapy administration may still give therapeutic advantages. In reality, a renoprotective impact of exogenous FGF21 had already been obviously indicated in db / db mice, resulting in reduced kidney injury through its positive impacts on metabolic parameters and ant fibrotic action. The connection between circulating FGF21 and CKD has been demonstrated by several clinical studies. A crosssectional study in adolescents living in the community revealed that serum FGF21 is related to kidney function and chronic kidney disease independently. In studies with CKD patients and healthy controls, levels of plasma FGF21 risen significantly with early-to-end CKD development and were related to renal function separately [33] . In ESRD patients with peritoneal dialysis, the circulating FGF-21 levels were also inversely correlated with the residual renal function. FGF21 concentrations are about 10 times greater in end-stage CKD patients than in normal subjects and about 4.5 times higher than patients with CKD in the early stages [33] . Two other studies in patients with ESRD dialysis showed that FGF21 levels were about 15 times higher in patients with acute hemodialysis and about 8 times higher in patients with peritoneal dialysis than in normal patients. In addition, Prospective cohort research in type two diabetes showed that the circulating concentration of FGF21 is a marker of the rapid development of CKD, which remains essential even after adjustment of the glomerular filtration baseline rate [32] . This outcome indicates that high concentrations of FGF21 may reflect procedures causally associated with kidney dysfunction in patients with type two diabetes, while decreased renal clearance is suggested as a significant cause raise of FGF21 [33] . The present study showed a significant correlation between Nrf2 in Albuminuria (* P<0.001). The mean Nrf2 was highest in macro albumin urea followed by micro albumin urea and lastly in Normo albumin urea. The present study showed significant positive correlation between Nrf2 and FGF21 (*P=0.001). No data to the best of our knowledge, yet available to compare the result with. Nrf2 increases hepatic Fgf21 expression and plasma FGF21 level in db/db and diet-induced obesity model mice. Furthermore, genetic induction of Nrf2 is found to lower plasma lipid levels in db/db diabetes model mice, and FGF21 is found to regulate expressions of glucose and lipid-metabolism-related genes in adipose tissues in mice.
